Correspondingly, IL-10 and TGF-β can drive the differentiation of monocytes into M2-like tumor-associated macrophages (TAMs), which amongst their other suppressive actions, can also compete with local dendritic cells (DCs) for tumor antigens and consequently inhibit T cell priming [46,56,57,58]. This evidence concerns the gene TGFB1 and neoplasm.